Industry

In the PLOS Blog Mind the Brain, James Coyne recounts how he wanted to participate in post-publication peer review surrounding the "bad science" in...

Young psychiatrist Jean Kim argues that psychiatrists need to reflect more on the morality of their work, then gets "laughed out of the room"...

A senior nurse who has been involved for 22 years with the University of Minnesota's psychiatric research program is accusing the university of a...

The Canadian Women's Health Network (CWHN), for two decades a major source of critical, independent research and information on women's health and mental health,...

Drug companies spent over $14 million from 2010 to 2013 to "woo" California doctors who specialize in treating foster children, according to part three...

The dramatic rise in ADHD spreading from the United States to the rest of the world is more an "economic and cultural plague" than...

A group of influential organizations are beginning an effort to change the entire way that psychiatric medications are named, according to a press release...

In the Daily Beast, Jay Michaelson struggles to make sense of the fact that the antipsychotic Abilify is America's top-selling drug, even while its...

The new Social Security Act, an Obamacare-inspired, Open Payments report came out September 30th. As part of the new healthcare reform policy, this federal report requires pharmaceutical and medical device companies to annually share documentation of direct payments they provided to entities such as medical practices and teaching hospitals. But before anyone gets excited and thinks there is finally a reliable and valid monitoring method to document that such payments are minimal as well as on the up and up, please note that 40% of the payment records (considered for inclusion in the 2013 Open Payments report) were not included in the $3.5 billion due to “unresolved questions” being cited.

Peter Gøtzsche's Deadly Medicines and Organised Crime has won first prize in the "Basis of Medicine" category of the British Medical Association's annual book...

A group of physicians and academics in Australia has launched a campaign to ban all pharmaceutical company sales representatives from visiting any medical doctors...

"The name of a 'new attention disorder' sounds like an Onion-style parody: sluggish cognitive tempo," writes Slate. "It also sounds like a classic case...

The European Medicines Agency has announced in a press release its final policies on the open publication of data from clinical trials. Ed Silverman...

AlterNet has published a feature story about prominent critical psychiatrist and MIA Foreign Correspondent David Healy, who "says his output and reputation have had...

People tend to strongly believe that pharmaceutical drugs with simpler and easier-to-pronounce names have fewer dangerous side effects, according to a study in the...

The New York Times has released Retro Report's ten-minute documentary video and essay looking at the birth and rise to fame of the SSRI...

"Opening the book on long-hidden industry relationships, the federal government revealed nearly $3.5 billion worth of payments and other ties that U.S. doctors and...

The new President-elect of the European Union Jean-Claude Juncker has removed key responsibilities relating to health and medicines from the government Commissioner in charge...

MIA Foreign Correspondent Peter Gøtzsche, author of the book Deadly Medicines and Organised Crime, was interviewed on Comedy Central's The Daily Show with Jon...

As a trauma survivor growing up in various adolescent mental health systems, I never learned any useful self-care tools or practices. I was taught that my current coping skills (self-injury, suicidal behavior, illicit drug use) were unacceptable, but not given any ideas as to what to replace them with. No one seemed to want to know much about the early childhood traumas that were driving these behaviors. Instead, I collected an assortment of diagnoses. I was told that I would be forever dependent on mediated relationships with professionals, and an ever-changing combination of pills. The message was that my troubles were chemical in nature and largely beyond my control.

Keris Myrick, MIA blogger and, as of today, the former chair of the board of the National Alliance for Mental Illness, will be the...

A study published today in Jama Psychiatry finds that mental health care ties with cancer for the third highest medical expense in the United...

After ten years of litigation, Pfizer has agreed to pay $325 million for marketing its anticonvulsant Neurontin for unapproved purposes.  The settlement comes six...

KMSP News has aired a report of yet another mentally ill man pressured to enroll in a study of an unapproved antipsychotic drug, with near-disastrous results. His story bears a striking resemblance to the case of Dan Markingson, who committed suicide in a University of Minnesota study in 2004.

Professor Leigh Turner of the University of Minnesota Center for Bioethics blasts the Board of Regents for ignoring psychiatric research abuse.